logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASCO 2019 — Nasopharyngeal carcinoma: gemcitabine+cisplatin followed by chemoradiotherapy delays recurrence

Significantly improved 3-year RFS vs CCRT alone.